| 101 |
18258594 | Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. | 2008 Apr 18 |
1 |
| 102 |
18491043 | Molecular understanding of copper and iron interaction with alpha-synuclein by fluorescence analysis. | 2008 Jul |
5 |
| 103 |
18585086 | Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease. | 2008 |
2 |
| 104 |
18823621 | Mathematical approach to understand the kinetics of alpha-synuclein aggregation: relevance to Parkinson's disease. | 2008 Oct |
2 |
| 105 |
17296847 | Adult-onset neurodegeneration with brain iron accumulation and cortical alpha-synuclein and tau pathology: a distinct clinicopathological entity. | 2007 Feb |
2 |
| 106 |
17325711 | The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element. | 2007 Mar |
1 |
| 107 |
17531952 | Thermodynamics imprinting reveals differential binding of metals to alpha-synuclein: relevance to Parkinson's disease. | 2007 Jul 20 |
1 |
| 108 |
17714865 | Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study. | 2007 Sep 7 |
1 |
| 109 |
16470637 | Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. | 2006 Feb |
1 |
| 110 |
17447435 | Green tea catechins as brain-permeable, non toxic iron chelators to "iron out iron" from the brain. | 2006 |
1 |
| 111 |
16000336 | Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. | 2005 Nov |
1 |
| 112 |
14742448 | Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide. | 2004 Apr 9 |
4 |
| 113 |
15196967 | Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells. | 2004 Jul 2 |
1 |
| 114 |
15231240 | Does cellular iron dysregulation play a causative role in Parkinson's disease? | 2004 Jul |
1 |
| 115 |
14502650 | Neuropathological spectrum of synucleinopathies. | 2003 Sep |
1 |
| 116 |
11843096 | Iron and Parkinson's disease. | 2002 Feb |
1 |
| 117 |
11850416 | Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein. | 2002 May 3 |
9 |
| 118 |
12196137 | Aggregation and neurotoxicity of alpha-synuclein and related peptides. | 2002 Aug |
2 |
| 119 |
12401952 | Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alpha-synuclein translocation in SK-N-SH cells in culture. | 2002 |
1 |
| 120 |
11677250 | Brain iron pathways and their relevance to Parkinson's disease. | 2001 Oct |
3 |
| 121 |
11724918 | Multiple system atrophy: cellular and molecular pathology. | 2001 Dec |
1 |
| 122 |
11733371 | Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. | 2001 Dec |
1 |
| 123 |
10878583 | Neuropathology of synuclein aggregates. | 2000 Jul 15 |
1 |
| 124 |
10934254 | The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. | 2000 Aug 15 |
5 |
| 125 |
11045680 | Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies. | 2000 Nov |
1 |
| 126 |
10208537 | Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. | 1999 Mar 17 |
4 |
| 127 |
10506125 | Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease. | 1999 Oct 8 |
3 |
| 128 |
9748051 | Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein. | 1998 Sep |
3 |